Since 2002, Sinocare has been dedicated to driving changes in the field of blood glucose monitoring with love and technology, and improving the lives of diabetes patients.
Sinocare was founded
Approved by NDRC(National Development and Reform Commission) as“Biomedical Engineering Model Project”
Listed on SZSE (Shenzhen Stock Exchange)
To be the leading BGMS manufacturer in Asia
Acquired Beijing Jianheng Diabetes Clinic
Acquisition of largest US based BGM manufacturer Nipro Diagnostic Inc.(Now renamed as Trividia Health Inc.)
Acquired PTS Diagnostics Inc
Hospital diabetes management system put into use
Awarded “ 2018 China Best Employer Enterprises Award”
AGEscan, a non-invasive diabetes risk screening product, opening a new entrance to the whole course management of diabetes
iPOCT standardization laboratory is marketed officially in CMEF Shanghai
The groundbreaking ceremony of sinocare iPOCT industrial park project is held
iPOCT Industrial Park was Put into Use
The continuous glucose monitoring (CGMS) product officially obtained the product registration certificate